D.E. Shaw & Co’s Enfusion, Inc. ENFN Stock Holding History

D.E. Shaw & Co’s Portfolio ENFN Stock Details ENFN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-233,604	Closed	-$2.6M	–	4824
2025 Q1	$2.6M	Buy	233,604 +137,907	+144%	+$1.52M	﹤0.01%	2412
2024 Q4	$986K	Buy	95,697 +65,475	+217%	+$633K	﹤0.01%	3210
2024 Q3	$287K	Buy	30,222 +16,840	+126%	+$145K	﹤0.01%	4004
2024 Q2	$114K	Buy	+13,382	New	+$122K	﹤0.01%	4150
2023 Q3	–	Sell	-39,419	Closed	-$442K	–	4546
2023 Q2	$442K	Sell	39,419 -79,599	-67%	-$706K	﹤0.01%	3472
2023 Q1	$1.25M	Buy	+119,018	New	+$1.31M	﹤0.01%	3010
2022 Q3	–	Sell	-46,404	Closed	-$474K	–	5594
2022 Q2	$474K	Buy	+46,404	New	+$513K	﹤0.01%	4118

Other funds holding ENFN

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

D.E. Shaw & Co's ENFN Position: Q2 2025 in Review

D.E. Shaw & Co sold out of Enfusion, Inc. (ENFN) in Q2 2025, closing a stake of 233,604 shares — an estimated $2.6M sold.

D.E. Shaw & Co first reported a position in ENFN in Q2 2022 and held it in 7 quarters. The position peaked at $2.6M in Q1 2025. 2 funds tracked by Wall St. Rank hold ENFN as of Q2 2025.

D.E. Shaw & Co reported no remaining Enfusion, Inc. position as of Q2 2025 after selling out during the quarter.
D.E. Shaw & Co sold 233,604 Enfusion, Inc. shares in Q2 2025, an estimated $2.6M.
D.E. Shaw & Co first reported a position in Enfusion, Inc. in Q2 2022 and held it in 7 quarters.
D.E. Shaw & Co's Enfusion, Inc. position peaked at $2.6M in Q1 2025.
2 funds tracked by Wall St. Rank held Enfusion, Inc. as of Q2 2025.

Based on D.E. Shaw & Co's 13F filing for Q2 2025, filed 14 Aug 2025.